Search

everythinglearnresearchcommunity

for

Search:↓

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Certain metabolites are lower in women with PCOS and could be potential markers for the condition.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Low prolactin in young women may increase heart and metabolism risks.

Women with mild acne are more likely to have polycystic ovary syndrome (PCOS) than those without acne.

High fasting insulin levels in women with PCOS are linked to a higher risk of heart and metabolic problems.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Obese Hispanic women with PCOS are at higher risk for metabolic problems than non-Hispanic white women.

Women with PCOS have similar bone density to healthy women, but those who are obese have higher bone density at some body sites.

Testosterone therapy seems safe for short-term use in postmenopausal women with low sexual desire, but more research on long-term effects is needed.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Women with acne have lower levels of a specific hormone marker than women without acne.

Women with PCOS are at high risk of glucose metabolism issues and heart diseases, especially if overweight, highlighting the need for early intervention.

Many young Egyptian women with PCOS also have fatty liver disease, especially if they are overweight and insulin resistant.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Screen young women with menstrual issues, acne, or excess hair for high cortisol to avoid misdiagnosis.

Women with hair loss had lower IGF-1 levels.

Women with prediabetes may have a higher risk of PCOS-like changes, especially if they have impaired glucose tolerance.

A holistic approach, including medical treatments, lifestyle changes, and mental health support, is crucial for managing hirsutism in women.

A postmenopausal woman's excessive hair growth and hair loss were due to a non-cancerous ovarian condition, treated successfully with surgery.

Lifestyle changes and medication can improve the quality of life for women with PCOS by reducing complications.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

Women with nonclassic congenital adrenal hyperplasia experience more sexual dysfunction and distress.

Women with PCOS have overall higher body fat, not abnormal fat placement, and more insulin resistance.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Finasteride improves hair loss in women with hyperandrogenism.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.